Blood pressures, heart rate and locomotor activity during salt loading and angiotensin II infusion in protease-activated receptor 2 (PAR2) knockout mice

BMC Physiology

Volumn 8, Issue 1, 2008, Pages

  McGuire, John J ^a   Van Vliet, Bruce N ^a   Halfyard, Sarah J ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; PROTEINASE ACTIVATED RECEPTOR 2; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; C57BL 6 MOUSE; C57BL MOUSE; CIRCADIAN RHYTHM; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; HEART RATE; HEMODYNAMICS; HYPERTENSION; KNOCKOUT MOUSE; LOCOMOTION; MALE; MOUSE; NONHUMAN; PULSE PRESSURE; SALT INTAKE; SALT LOADING; STRAIN DIFFERENCE; SYSTOLIC BLOOD PRESSURE; ANIMAL; BIOSYNTHESIS; COMPARATIVE STUDY; DRUG EFFECT; GENETICS; INTRAVENOUS DRUG ADMINISTRATION; MOTOR ACTIVITY; MOUSE MUTANT; PHENOTYPE; PHYSIOLOGY; TRANSGENIC MOUSE;

ANGIOTENSIN II; ANIMALS; BLOOD PRESSURE; HEART RATE; INFUSIONS, INTRAVENOUS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; MOTOR ACTIVITY; PHENOTYPE; RECEPTOR, PAR-2; SODIUM CHLORIDE, DIETARY;

EID: 54949091872     PISSN: None     EISSN: 14726793     Source Type: Journal    
DOI: 10.1186/1472-6793-8-20     Document Type: Article

References (43)

1. International Union of Pharmacology. XXVIII. Proteinase-activated receptors. MD Hollenberg SJ Compton, Pharmacol Rev 2002 54 203 217 10.1124/pr.54.2.203 12037136
2. Proteinase-activated receptors. SR Macfarlane MJ Seatter T Kanke GD Hunter R Plevin, Pharmacol Rev 2001 53 245 282 11356985
3. Proteinase-activated Receptor 2 (PAR2): a challenging new target for treatment of vascular diseases. JJ McGuire, Curr Pharm Des 2004 10 2769 2778 10.2174/1381612043383656 15320742
4. Cardiovascular responses mediated by protease-activated receptor-2 (PAR- 2) and thrombin receptor (PAR-1) are distinguished in mice deficient in PAR-2 or PAR-1. BP Damiano WM Cheung RJ Santulli WP Fung-Leung K Ngo RD Ye, J Pharmacol Exp Ther 1999 288 671 678 9918574
5. Essential role for proteinase-activated receptor-2 in arthritis. WR Ferrell JC Lockhart EB Kelso L Dunning R Plevin SE Meek, J Clin Invest 2003 111 35 41 12511586
6. Therapeutic promise of proteinase-activated receptor-2 antagonism in joint inflammation. EB Kelso JC Lockhart T Hembrough L Dunning R Plevin MD Hollenberg, J Pharmacol Exp Ther 2006 316 1017 1024 10.1124/jpet.105.093807 16260582
7. Induction of intestinal inflammation in mouse by activation of proteinase-activated receptor-2. N Cenac AM Coelho C Nguyen S Compton P Andrade-Gordon WK MacNaughton, Am J Pathol 2002 161 1903 1915 12414536
8. Protease-activated receptor 2 mediates eosinophil infiltration and hyperreactivity in allergic inflammation of the airway. F Schmidlin S Amadesi K Dabbagh DE Lewis P Knott NW Bunnett, J Immunol 2002 169 5315 5321 12391252
9. Delayed onset of inflammation in protease-activated receptor-2-deficient mice. JR Lindner ML Kahn SR Coughlin GR Sambrano E Schauble D Bernstein, J Immunol 2000 165 6504 6510 11086091
10. PAR-2 mediates increased inflammatory cell adhesion and neointima formation following vascular injury in the mouse. GM Tennant RM Wadsworth S Kennedy, Atherosclerosis 2008 198 57 64 17996873
11. Protease-activated receptor-2 augments experimental crescentic glomerulonephritis. L Moussa J Apostolopoulos P Davenport J Tchongue PG Tipping, Am J Pathol 2007 171 800 808 17640968 10.2353/ajpath.2007.061155
12. Proteinase-activated receptor-2 induction by neuroinflammation prevents neuronal death during HIV infection. F Noorbakhsh N Vergnolle JC McArthur C Silva M Vodjgani P Andrade-Gordon, J Immunol 2005 174 7320 7329 15905579
13. Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis. F Noorbakhsh S Tsutsui N Vergnolle LA Boven N Shariat M Vodjgani, J Exp Med 2006 203 425 435 16476770 10.1084/jem.20052148
14. Deficiency of PAR-2 gene increases acute focal ischemic brain injury. G Jin T Hayashi J Kawagoe T Takizawa T Nagata I Nagano, J Cereb Blood Flow Metab 2005 25 3 302 313 10.1038/sj.jcbfm.9600021 15647743
15. Roles of protease-activated receptors in a mouse model of endotoxemia. E Camerer I Cornelissen H Kataoka DN Duong YW Zheng SR Coughlin, Blood 2006 107 3912 3921 16434493 10.1182/blood-2005-08-3130
16. Tissue factor deficiency and PAR-1 deficiency are protective against renal ischemia reperfusion injury. J Sevastos SE Kennedy DR Davis M Sam PW Peake JA Charlesworth, Blood 2007 109 577 583 10.1182/blood-2006-03-008870 16990608
17. Increased salt-sensitivity in endothelial nitric oxide synthase-knockout mice. AM Leonard LL Chafe JP Montani BN Van Vliet, Am J Hypertens 2006 19 1264 1269 10.1016/j.amjhyper.2006.05.025 17161773
18. Effect of hyperhomocystinemia and hypertension on endothelial function in methylenetetrahydrofolate reductase-deficient mice. A Virdis M Iglarz MF Neves F Amiri RM Touyz R Rozen, Arterioscler Thromb Vasc Biol 2003 23 1352 1357 10.1161/01.ATV.0000083297.47245.DA 12829522
19. Reduced vascular remodeling, endothelial dysfunction, and oxidative stress in resistance arteries of angiotensin II-infused macrophage colony-stimulating factor-deficient mice: evidence for a role in inflammation in angiotensin-induced vascular injury. C De Ciuceis F Amiri P Brassard DH Endemann RM Touyz EL Schiffrin, Arterioscler Thromb Vasc Biol 2005 25 2106 2113 10.1161/01.ATV.0000181743.28028.57 16100037
20. The renal kallikrein-kinin system and the regulation of salt and water excretion. IH Mills NA Macfarlane PE Ward LF Obika, Fed Proc 1976 35 181 188 765162
21. Long-term infusion of kallikrein attenuates renal injury in Dahl salt-sensitive rats. Y Uehara N Hirawa A Numabe Y Kawabata T Ikeda T Gomi, Am J Hypertens 1997 10 83S 88S 9160787
22. The renal kallikrein-kinin system: its role as a safety valve for excess sodium intake, and its attenuation as a possible etiologic factor in salt-sensitive hypertension. M Katori M Majima, Crit Rev Clin Lab Sci 2003 40 43 115 10.1080/713609329 12627748
23. Differential regulation of endothelial exocytosis of P-selectin and von Willebrand factor by protease-activated receptors and cAMP. JH Cleator WQ Zhu DE Vaughan HE Hamm, Blood 2006 107 2736 2744 16332977 10.1182/blood-2004-07-2698
24. Activation of mouse protease-activated receptor-2 induces lymphocyte adhesion and generation of reactive oxygen species. SY Lim GM Tennant S Kennedy CL Wainwright KA Kane, Br J Pharmacol 2006 149 591 599 16981001 10.1038/sj.bjp.0706905
25. Induction of IL-6 release from human T cells by PAR-1 and PAR-2 agonists. T Li S He, Immunol Cell Biol 2006 84 461 466 10.1111/j.1440-1711.2006.01456.x 16869943
26. Upregulation of proteinase-activated receptors and hypercontractile responses precede development of arterial lesions after balloon injury. R Fukunaga K Hirano M Hirano N Niiro J Nishimura Y Maehara, Am J Physiol Heart Circ Physiol 2006 291 H2388 H2395 10.1152/ajpheart.01313.2005 16844909
27. Cyclooxygenase-2 induction and prostacyclin release by protease-activated receptors in endothelial cells require cooperation between mitogen-activated protein kinase and NF-kappaB pathways. F Syeda J Grosjean RA Houliston RJ Keogh TD Carter E Paleolog, J Biol Chem 2006 281 11792 11804 10.1074/jbc.M509292200 16467309
28. Jab1, a novel protease-activated receptor-2 (PAR-2)-interacting protein, is involved in PAR-2-induced activation of activator protein-1. W Luo Y Wang T Hanck R Stricker G Reiser, J Biol Chem 2006 281 7927 7936 10.1074/jbc.M510784200 16410250
29. Cytokine upregulation of proteinase-activated-receptors 2 and 4 expression mediated by p38 MAP kinase and inhibitory kappa B kinase beta in human endothelial cells. E Ritchie M Saka C Mackenzie R Drummond C Wheeler-Jones T Kanke, Br J Pharmacol 2007 150 1044 1054 17339845 10.1038/sj.bjp.0707150
30. Vascular endothelial cell-specific NF-kappaB suppression attenuates hypertension-induced renal damage. N Henke R Schmidt-Ullrich R Dechend JK Park F Qadri M Wellner, Circ Res 2007 101 268 276 10.1161/CIRCRESAHA.107.150474 17585070
31. Characteristics of 24 h telemetered blood pressure in eNOS-knockout and C57Bl/6J control mice. BN Van Vliet LL Chafe JP Montani, J Physiol 2003 549 313 325 12665600 10.1113/jphysiol.2003.041897
32. Persistence of PAR-2 vasodilation despite endothelial dysfunction in BPH/2 hypertensive mice. JJ McGuire BN Van Vliet J Gimenez JC King SJ Halfyard, Pflugers Arch 2007 454 535 543 10.1007/s00424-007-0226-2 17318644
33. Phenotyping the level of mouse blood pressure by telemetry. BN Van Vliet JJ McGuire L Chafe A Leonard A Joshi JP Montani, Clin Exp Pharmacol Physiol 2006 33 1007 1015 10.1111/j.1440-1681.2006.04479.x 17042907
34. Recommendations for blood pressure measurement in humans and experimental animals. Part 2: Blood pressure measurement in experimental animals: a statement for professionals from the subcommittee of professional and public education of the American Heart Association council on high blood pressure research. TW Kurtz KA Griffin AK Bidani RL Davisson JE Hall, Hypertension 2005 45 299 310 10.1161/01.HYP.0000150857.39919.cb 15611363
35. Effects of Poststroke Losartan Versus Captopril Treatment on Myogenic and Endothelial Function in the Cerebrovasculature of SHRsp. JS Smeda JJ McGuire, Stroke 2007 38 1590 1596 10.1161/STROKEAHA.106.475087 17379826
36. Hyperpolarization of murine small caliber mesenteric arteries by activation of endothelial proteinase-activated receptor 2. JJ McGuire MD Hollenberg BM Bennett CR Triggle, Can J Physiol Pharmacol 2004 82 1103 1112 10.1139/y04-121 15644953
37. Multiple mechanisms of vascular smooth muscle relaxation by the activation of proteinase-activated receptor 2 in mouse mesenteric arterioles. JJ McGuire MD Hollenberg P Andrade-Gordon CR Triggle, Br J Pharmacol 2002 135 155 169 11786491 10.1038/sj.bjp.0704469
38. Proteinase-activated receptor-2 (PAR2): vascular effects of a PAR2-derived activating peptide via a receptor different than PAR2. JJ McGuire J Dai P Andrade-Gordon CR Triggle MD Hollenberg, J Pharmacol Exp Ther 2002 303 985 992 10.1124/jpet.102.040352 12438518
39. Kallikrein-mediated cell signalling: targeting proteinase-activated receptors (PARs). K Oikonomopoulou KK Hansen M Saifeddine N Vergnolle I Tea M Blaber, Biol Chem 2006 387 817 824 10.1515/BC.2006.104 16800746
40. Renal kallikrein-kinin system damage and salt sensitivity: insights from experimental models. LG Ardiles CD Figueroa SA Mezzano, Kidney Int Suppl 2003 S2 S8 10.1046/j.1523-1755.64.s86.2.x 12969120
41. A missing link between a high salt intake and blood pressure increase. M Katori M Majima, J Pharmacol Sci 2006 100 370 390 10.1254/jphs.CRJ06003X 16651701
42. Targeted disruption of the bradykinin B(2) receptor gene in mice alters the ontogeny of the renin-angiotensin system. IV Yosipiv S Dipp SS El-Dahr, Am J Physiol Renal Physiol 2001 281 F795 F801 11592936
43. Importance of the blood pressure-heart rate relationship. B Folkow D Ely, Blood Press 1998 7 133 138 10.1080/080370598437321 9758081